Overall Status

Completed (565)

Unknown status (115)

Recruiting (110)

Terminated (95)

Not yet recruiting (52)

Active, not recruiting (28)

Withdrawn (27)

Suspended (6)

Enrolling by invitation (5)

Phase

phase 2 (228)

n/a (178)

phase 3 (170)

phase 4 (120)

phase 1 (65)

phase 1/phase 2 (47)

phase 2/phase 3 (28)

early phase 1 (10)

Study Documents

Annotated Case Report Form (6)

Clinical Study Report (6)

Dataset Specification (6)

Individual Participant Data Set (6)

Informed Consent Form (6)

Statistical Analysis Plan (6)

Study Protocol (6)

EMA EudraCT Results (1)

Funder Type

Other (635)

Industry (336)

NIH (24)

U.S. Fed (8)

Study Type

Interventional (846)

Observational (148)

Observational [Patient Registry] (9)

erythropoietin

Showing 1001 - 1003 of 1,003

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HIV, Cytopenias Trial in Raritan (Epoetin alfa)

Completed

HIV Infections
Cytopenias

Epoetin alfa

Raritan, New Jersey

Ortho Pharmaceutical Corp

Jun 23, 2005

HIV, Cytopenias Trial in Raritan (Epoetin alfa)

Completed

HIV Infections
Cytopenias

Epoetin alfa

Raritan, New Jersey

Ortho Pharmaceutical Corp

Jun 23, 2005

HIV, Cytopenias Trial in Raritan (Epoetin alfa)

Completed

HIV Infections
Cytopenias

Epoetin alfa

Raritan, New Jersey

Ortho Pharmaceutical Corp

Jun 23, 2005